Nervous market has been hard on Nektar; hold options in my Volatility Portfolio for September news (and beyond)

Incyte up on positive trial results

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
Ionis gets hit hard in biotech pullback

Ionis gets hit hard in biotech pullback

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...